Clinical Trials Browser

Carcinoma × calcipotriene × Clear all

NCT03370406 2026-06-01

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

Phase 1 Recruiting

Carcinoma, Carcinoma, Squamous Cell